Skip to content

Storage Symptom After Laser Prostatectomy

Change in Storage Symptoms Following Laser Prostatectomy: Comparison Between Potassium-titanyl-phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02073799
Enrollment
486
Registered
2014-02-27
Start date
2014-02-28
Completion date
Unknown
Last updated
2014-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Hyperplasia

Brief summary

Recent literature indicated that postoperative storage symptoms after Photoselective vaporization of the prostate (PVP) or holmium laser enucleation of the prostate (HoLEP) were often reported and generally more common than after transurethral prostatectomy (TURP). However, almost all literature focused on postoperative urgency or dysuria immediately after PVP or HoLEP. Thus, there has been a scarcity of data on serial changes of storage symptoms in the postoperative period after PVP or HoLEP and data on predicting factors that influence improvement in storage symptoms postoperatively. The aim of this study was to compare serial changes of postoperative storage symptoms between PVP and HoLEP, and to identify the predictors that influence improvement of storage symptoms postoperatively.

Interventions

PROCEDURELaser prostatectomy (Photoselective vaporization of the prostate or Holmium laser enucleation of the prostate)

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of prostatic hyperplasia * underwent photoselective vaporization of the prostate or holmium laser enucleation of the prostate * 12-months follow-up data were available

Exclusion criteria

* previous diagnosis of urethral stricture, prostate carcinoma, and neurogenic bladder disease

Design outcomes

Primary

MeasureTime frameDescription
the subtotal storage symptom score of the International Prostate Symptom Score (IPSS)12 months after surgerya reduction by ≥ 50% of the subtotal storage symptom score according to the International Prostate Symptom Score (IPSS) after the surgery compared to baseline

Countries

South Korea

Contacts

Primary ContactJae-Seung Paick, doctor of philosophy
jspaick@snu.ac.kr82-2-2072-2422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026